Effects of Cardiovascular Disease Risk Communication for Patients With Type 2 Diabetes on Risk Perception in a Randomized Controlled Trial The @RISK Study
| Autor: | Giel Nijpels, Sandra D.M. Bot, Trudy van der Weijden, Laura M C Welschen, Piet J. Kostense, Jacqueline M. Dekker, Danielle R.M. Timmermans |
|---|---|
| Přispěvatelé: | General practice, Epidemiology and Data Science, Public and occupational health, EMGO - Lifestyle, overweight and diabetes, EMGO+ - Lifestyle, Overweight and Diabetes, Family Medicine, RS: CAPHRI School for Public Health and Primary Care |
| Rok vydání: | 2012 |
| Předmět: |
Research design
medicine.medical_specialty Endocrinology Diabetes and Metabolism media_common.quotation_subject Type 2 diabetes law.invention Randomized controlled trial SDG 3 - Good Health and Well-being law Internal Medicine Medicine Humans media_common Netherlands Original Research Advanced and Specialized Nursing business.industry Communication Clinical Care/Education/Nutrition/Psychosocial Research Type 2 Diabetes Mellitus medicine.disease Risk perception Diabetes Mellitus Type 2 Cardiovascular Diseases Physical therapy Managed care Anxiety Perception medicine.symptom Worry business |
| Zdroj: | Diabetes Care, 35(12), 2485-2492. American Diabetes Association Inc. Diabetes Care Welschen, L M C, Bot, S D M, Kostense, P J, Dekker, J M, Timmermans, D R M, van der Weijden, T & Nijpels, G 2012, ' Effects of Cardiovascular Disease Risk Communication for Patients With Type 2 Diabetes on Risk Perception in a Randomized Controlled Trial The @RISK Study ', Diabetes Care, vol. 35, no. 12, pp. 2485-2492 . https://doi.org/10.2337/dc11-2130 Diabetes Care, 35(12), 2485-2492. American Diabetes Association |
| ISSN: | 0149-5992 |
| DOI: | 10.2337/dc11-2130 |
| Popis: | OBJECTIVE Patients with type 2 diabetes mellitus (T2DM) underestimate their risk of developing severe complications, and they do not always understand the risk communication by their caregivers. The aim of this study was to investigate the effects of an intervention focused on the communication of the absolute 10-year risk of developing cardiovascular disease (CVD) in patients with T2DM. RESEARCH DESIGN AND METHODS A randomized controlled trial was performed in T2DM patients newly referred to the Diabetes Care System (DCS) West-Friesland, a managed-care system in the Netherlands. The intervention group (n = 131) received a six-step CVD risk communication. Control subjects (n = 130) received standard managed care. The primary outcome measure was appropriateness of risk perception (difference between actual CVD risk calculated by the UK Prospective Diabetes Study risk engine and risk perception). Secondary outcome measures were illness perceptions, attitude and intention to change behavior, satisfaction with the communication, and anxiety and worry about CVD risk. Patients completed questionnaires at baseline, at 2 weeks (immediately after the intervention), and at 12 weeks. RESULTS Appropriateness of risk perception improved between the intervention and control groups at 2 weeks. This effect disappeared at 12 weeks. No effects were found on illness perceptions, attitude and intention to change behavior, or anxiety and worry about CVD risk. Patients in the intervention group were significantly more satisfied with the communication. CONCLUSIONS This risk communication method improved patients’ risk perception at 2 weeks but not at 12 weeks. Negative effects were not found, as patients did not become anxious or worried after the CVD risk communication. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|